Serquiña, Analyn S.
HRN: 14-46-27 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/08/2024
CEFUROXIME 1.5GM (VIAL)
11/08/2024
11/09/2024
IV
1.5gm
Q8 3 Doses
S/P LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes